Today: March 22, 2018, 6:13 pm

Karolinska Developments's portfolio company Modus Therapeutics recruits new Chief Medical Officer 2017-09-14 08:04:01

STOCKHOLM - 14 September 2017. Karolinska Development's portfolio company Modus Therapeutics AB, which's drug candidate sevuparin is currently in a phase II study for treatment of patients with sickle cell disease, has recruited Professor Thomas Knittel as its new Chief Medical Officer (CMO).

Thomas Knittel (b. 1962), M.D., Ph.D. from University of Mainz with a speciality in internal medicine and medical gastroenterology and MBA from Kellogg School of Management/WHU, has more than 10 years of clinical experience from internal medicine and over 15 years of experience from research and development, medical affairs and marketing within the pharmaceutical industry.

Thomas Knittel formally took up his appointment at Modus Therapeutics in mid-August2017.

Further information and comments from Modus Therapeutics' CEO Ellen K Donnelly and Thomas Knittel are available at the link below:

For further information, please contact:

Viktor Drvota, CEO, Karolinska Development AB
Phone: +46 73 982 52 02, e-mail:


About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.

Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.

Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.

The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.

For more information, please visit

News release Modus Therapeutics new CMO (ENG)

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via Globenewswire

# 520 Words
Related Articles
More From The Author
Fun and Functional Helsinki – Simply the [..]
Helsinki is the most liveable city in the Nordic region and the ninth best in the world. Safe and functional, [..]
Zycus Hires Amit Bhatia as Business Head [..]
Zycus : Amit Bhatia comes to Zycus with 19 years of experience in such companies as Genpact and SAP. He [..]
NADL - NADL Receives Court Approval of [..]
Hamilton, Bermuda, September 13, 2017 - North Atlantic Drilling Ltd. ("NADL" or the "Company"), a majority owned [..]
SDRL - Seadrill Receives Court Approval of [..]
Hamilton, Bermuda, September 13, 2017 - Seadrill Limited ("Seadrill" or the "Company") announces today that [..]
Edwards Vacuum Receives Lam Research’s 2017 Supplier [..]
Edwards Vacuum has been recognized with a 2017 Supplier Excellence Award from Lam Research Corp. (Nasdaq: LRCX), a global supplier [..]
More From Business
RCBC Bankard launches new Platinum card with [..]
Manila, Philippines and Tokyo, Japan, Mar 22, 2018 - (ACN Newswire) - JCB International Co., Ltd. (JCBI), the international operations [..]
Project Laneways Offers Change Management Courses in [..]
Project Laneways has announced it will be conducting change management courses in Canberra in May. The Change Management Foundation [..]
Jaguar Leaps Onto The SUV Bandwagon With [..]
When it came to jumping on the SUV bandwagon, it was inevitable that Jaguar would make the leap; after all, [..]
Bright Light Stocks Independent Control Systems for [..]
Through their website Bright Light provides a range of independent control systems that will provide both hardwired and wireless [..]
Easy, Convenient and Time-saving: Steam Cleaning Without [..]
Kärcher Steam Cleaners give you the experience of cleaning chemical-free, killing 99.99% of common household bacteria, santitise [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.